One-year average price target for Instil Bio (NasdaqCM:TIL) was revised up to $67.32/share, a 24.53% increase from the prior $54.06 target dated March 25, 2026. The figure represents the average of multiple analyst targets and signals a positive analyst reassessment that could support modest upside in the stock.
One-year average price target for Instil Bio (NasdaqCM:TIL) was revised up to $67.32/share, a 24.53% increase from the prior $54.06 target dated March 25, 2026. The figure represents the average of multiple analyst targets and signals a positive analyst reassessment that could support modest upside in the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
